Muhammad Babur

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action.

Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action.

Journal: Cancer research communications

Published: June 12, 2024

Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts.

Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts.

Journal: Cancer genomics & proteomics

Published: April 05, 2024

Habitat Imaging of Tumors Enables High Confidence Sub-Regional Assessment of Response to Therapy.

Habitat Imaging of Tumors Enables High Confidence Sub-Regional Assessment of Response to Therapy.

Journal: Cancers

Published: March 07, 2022

Targeting the MAPK7/MMP9 axis for metastasis in primary bone cancer.

Targeting the MAPK7/MMP9 axis for metastasis in primary bone cancer.

Journal: Oncogene

Published: March 17, 2020

Diffusion model comparison identifies distinct tumor sub-regions and tracks treatment response.

Diffusion model comparison identifies distinct tumor sub-regions and tracks treatment response.

Journal: Magnetic resonance in medicine

Published: October 01, 2019

Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non-small Cell Lung Cancer.

Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non-small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 07, 2018

A new method for the high-precision assessment of tumor changes in response to treatment.

A new method for the high-precision assessment of tumor changes in response to treatment.

Journal: Bioinformatics (Oxford, England)

Published: July 27, 2017

Data-driven mapping of hypoxia-related tumor heterogeneity using DCE-MRI and OE-MRI.

Data-driven mapping of hypoxia-related tumor heterogeneity using DCE-MRI and OE-MRI.

Journal: Magnetic resonance in medicine

Published: April 01, 2017

Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.

Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.

Journal: PloS one

Published: October 28, 2015

Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models.

Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models.

Journal: Cancer research

Published: July 30, 2015

Dissemination via the lymphatic or angiogenic route impacts the pathology, microenvironment and hypoxia-related drug response of lung metastases.

Dissemination via the lymphatic or angiogenic route impacts the pathology, microenvironment and hypoxia-related drug response of lung metastases.

Journal: Clinical & experimental metastasis

Published: January 13, 2015

Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself.

Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself.

Journal: PloS one

Published: September 05, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026